Willemijn Plieger-van Solkema

ORCID: 0000-0003-3911-477X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Childhood Cancer Survivors' Quality of Life
  • Ethics in Clinical Research
  • Epigenetics and DNA Methylation
  • Pharmaceutical studies and practices

Stichting Kinderoncologie Nederland
2024

Importance In poor-prognosis children’s cancers, new therapies may carry fresh hope for patients and parents. However, there is an absolute requirement any therapy to be properly evaluated fulfill scientific, regulatory, reimbursement requirements. Randomized clinical trials (RCTs) are considered the gold standard, but no consensus exists on how when they should deployed best meet needs of all stakeholders. Objective To conduct a multistakeholder meeting foster greater shared understanding...

10.1001/jamanetworkopen.2024.49239 article EN cc-by-nc-nd JAMA Network Open 2024-12-06
Coming Soon ...